Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016

Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We us...

Full description

Bibliographic Details
Published in:The Lancet
Main Authors: Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J., Abdelalim, A., Abebe, Z., Ärnlöv, Johan, Lozano, R.
Format: Article in Journal/Newspaper
Language:English
Published: Högskolan Dalarna, Medicinsk vetenskap 2018
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:du-41115
https://doi.org/10.1016/S0140-6736(18)30994-2
id ftunivdalarna:oai:DiVA.org:du-41115
record_format openpolar
institution Open Polar
collection Dalarna University: Publications (DiVA)
op_collection_id ftunivdalarna
language English
topic Communicable Diseases
Global Burden of Disease
Health Services Accessibility
Humans
Noncommunicable Diseases
Quality of Health Care
Wounds and Injuries
adolescent
aged
Article
cancer mortality
cancer registry
cancer survival
communicable disease
disease burden
environmental exposure
health care access
health care policy
health care quality
health care system
health service
high risk behavior
human
maternal disease
newborn disease
non communicable disease
performance measurement system
priority journal
global disease burden
health care delivery
injury
Public Health
Global Health
Social Medicine and Epidemiology
Folkhälsovetenskap
global hälsa
socialmedicin och epidemiologi
spellingShingle Communicable Diseases
Global Burden of Disease
Health Services Accessibility
Humans
Noncommunicable Diseases
Quality of Health Care
Wounds and Injuries
adolescent
aged
Article
cancer mortality
cancer registry
cancer survival
communicable disease
disease burden
environmental exposure
health care access
health care policy
health care quality
health care system
health service
high risk behavior
human
maternal disease
newborn disease
non communicable disease
performance measurement system
priority journal
global disease burden
health care delivery
injury
Public Health
Global Health
Social Medicine and Epidemiology
Folkhälsovetenskap
global hälsa
socialmedicin och epidemiologi
Fullman, N.
Yearwood, J.
Abay, S. M.
Abbafati, C.
Abd-Allah, F.
Abdela, J.
Abdelalim, A.
Abebe, Z.
Ärnlöv, Johan
Lozano, R.
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
topic_facet Communicable Diseases
Global Burden of Disease
Health Services Accessibility
Humans
Noncommunicable Diseases
Quality of Health Care
Wounds and Injuries
adolescent
aged
Article
cancer mortality
cancer registry
cancer survival
communicable disease
disease burden
environmental exposure
health care access
health care policy
health care quality
health care system
health service
high risk behavior
human
maternal disease
newborn disease
non communicable disease
performance measurement system
priority journal
global disease burden
health care delivery
injury
Public Health
Global Health
Social Medicine and Epidemiology
Folkhälsovetenskap
global hälsa
socialmedicin och epidemiologi
description Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations. Copyright © 2018 The Author(s). Published by Elsevier Ltd.
format Article in Journal/Newspaper
author Fullman, N.
Yearwood, J.
Abay, S. M.
Abbafati, C.
Abd-Allah, F.
Abdela, J.
Abdelalim, A.
Abebe, Z.
Ärnlöv, Johan
Lozano, R.
author_facet Fullman, N.
Yearwood, J.
Abay, S. M.
Abbafati, C.
Abd-Allah, F.
Abdela, J.
Abdelalim, A.
Abebe, Z.
Ärnlöv, Johan
Lozano, R.
author_sort Fullman, N.
title Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
title_short Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
title_full Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
title_fullStr Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
title_full_unstemmed Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016
title_sort measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations : a systematic analysis from the global burden of disease study 2016
publisher Högskolan Dalarna, Medicinsk vetenskap
publishDate 2018
url http://urn.kb.se/resolve?urn=urn:nbn:se:du-41115
https://doi.org/10.1016/S0140-6736(18)30994-2
geographic Norway
geographic_facet Norway
genre Iceland
genre_facet Iceland
op_relation The Lancet, 0140-6736, 2018, 391:10136, s. 2236-2271
orcid:0000-0002-6933-4637
http://urn.kb.se/resolve?urn=urn:nbn:se:du-41115
doi:10.1016/S0140-6736(18)30994-2
PMID 29893224
ISI:000433904700029
Scopus 2-s2.0-85047728707
op_rights info:eu-repo/semantics/openAccess
op_doi https://doi.org/10.1016/S0140-6736(18)30994-2
container_title The Lancet
container_volume 391
container_issue 10136
container_start_page 2236
op_container_end_page 2271
_version_ 1766044036016111616
spelling ftunivdalarna:oai:DiVA.org:du-41115 2023-05-15T16:53:29+02:00 Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : A systematic analysis from the Global Burden of Disease Study 2016 Fullman, N. Yearwood, J. Abay, S. M. Abbafati, C. Abd-Allah, F. Abdela, J. Abdelalim, A. Abebe, Z. Ärnlöv, Johan Lozano, R. 2018 application/pdf http://urn.kb.se/resolve?urn=urn:nbn:se:du-41115 https://doi.org/10.1016/S0140-6736(18)30994-2 eng eng Högskolan Dalarna, Medicinsk vetenskap Lancet Publishing Group The Lancet, 0140-6736, 2018, 391:10136, s. 2236-2271 orcid:0000-0002-6933-4637 http://urn.kb.se/resolve?urn=urn:nbn:se:du-41115 doi:10.1016/S0140-6736(18)30994-2 PMID 29893224 ISI:000433904700029 Scopus 2-s2.0-85047728707 info:eu-repo/semantics/openAccess Communicable Diseases Global Burden of Disease Health Services Accessibility Humans Noncommunicable Diseases Quality of Health Care Wounds and Injuries adolescent aged Article cancer mortality cancer registry cancer survival communicable disease disease burden environmental exposure health care access health care policy health care quality health care system health service high risk behavior human maternal disease newborn disease non communicable disease performance measurement system priority journal global disease burden health care delivery injury Public Health Global Health Social Medicine and Epidemiology Folkhälsovetenskap global hälsa socialmedicin och epidemiologi Article in journal info:eu-repo/semantics/article text 2018 ftunivdalarna https://doi.org/10.1016/S0140-6736(18)30994-2 2022-04-13T19:18:21Z Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations. Copyright © 2018 The Author(s). Published by Elsevier Ltd. Article in Journal/Newspaper Iceland Dalarna University: Publications (DiVA) Norway The Lancet 391 10136 2236 2271